Top compounds associated with response to B3GNT4


Feature Type Standardized
Nominal ANOVA
mRNA BI-2536 GDSC1000 pan-cancer AAC 0.049 0.4
mRNA YK 4-279 GDSC1000 pan-cancer AAC 0.033 0.4
mRNA ML312 CTRPv2 pan-cancer AAC -0.062 0.4
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.028 0.4
mRNA parbendazole CTRPv2 pan-cancer AAC 0.027 0.4
mRNA FQI-1 CTRPv2 pan-cancer AAC 0.039 0.4
mRNA AGK-2 CTRPv2 pan-cancer AAC -0.033 0.4
mRNA Panobinostat CCLE pan-cancer AAC 0.038 0.4
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.032 0.4
mRNA Tipifarnib FIMM pan-cancer AAC -0.11 0.4
Download CSV